ResearcherNational Sun Yat-sen UniversityNo recent work listed

Jing‐Ru Weng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4934-9126; OpenAlex author ID A5054738938. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper

Papers 1

OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. Last author DOI 10.18632/oncotarget.16450 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yi-Jin Chen · 1 shared paper, 2017 · strength 0.08
- Paper OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. DOI 10.18632/oncotarget.16450 ↗
Wan-Chi Tsai · 1 shared paper, 2017 · strength 0.08
- Paper OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. DOI 10.18632/oncotarget.16450 ↗
Po‐Chen Chu · 1 shared paper, 2017 · strength 0.08
- Paper OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. DOI 10.18632/oncotarget.16450 ↗
Li‐Yuan Bai · 1 shared paper, 2017 · strength 0.08
- Paper OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. DOI 10.18632/oncotarget.16450 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.